BIVI
Biovie IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$11.08M
P/E Ratio
—
EPS
$-3.28
Beta
0.56
52W High
$13.20
52W Low
$1.06
50-Day MA
$1.30
200-Day MA
$2.63
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biovie Inc
BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. The company is headquartered in Santa Monica, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-17.97M |
| Operating Margin | 0.00% |
| Return on Equity | -80.70% |
| Return on Assets | -47.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.56 |
| Price-to-Book | 0.56 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -11.66 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $7.54M |
| Float | $7.50M |
| % Insiders | 0.36% |
| % Institutions | 15.64% |
Data last updated: 4/7/2026